The aim was to assess endothelial function with photoplethysmography (PPG), by post-occlusive reactive hyperaemia (PORH) combined with alprostadil challenge test in patients with peripheral artery disease (PAD). Methods: Forty-nine PAD patients stage II-III Fontaine (39 male, 10 female, mean age 68.45±5.86 years) and a control group of 49 healthy individuals (24 male, 25 female; mean age 25.1±3.8 for a young subgroup; 71.0±0.16 years for an elderly subgroup) were included. Ankle-brachial index (ABI) was assessed at baseline, peripheral perfusion (PP) and PORH were assessed at baseline and after the 30 minutes administration of parenteral alprostadil. Results: After 3 minutes of arterial occlusion, peripheral perfusion increased from 0.69±0.94 mV/V to 2.27±2.42 mV/V (p<0.0001). After alprostadil challenge, peripheral perfusion increased from 0.84±1.24 mV/V to 4.52±3.52 mV/V (p<0.0001). In controls PP was 2.4±1.7 mV/V versus 3.8±1.5 mV/V, p<0.0001. Conclusion: In patients with PAD, an increase in PORH after alprostadil challenge due to the release of nitric oxide (NO), provides information on the endothelial function and could reflect the presence of collaterals. In the healthy control group, the increase in PORH could reflect the integrity of main arterial branch. In PAD patients with an increase in PORH, conservative therapy should be preferred over surgical revascularisation.
Background
The prevalence of peripheral arterial disease (PAD) of the lower limb is rising and it is still underdiagnosed [1] . Despite a decrease in ankle-brachial index (ABI), only one-half of the population with occlusive atherosclerotic vascular disease is symptomatic [2] . This compensatory mechanism might be present in case of progressive arterial occlusion, accompanied by the development of collateral blood vessels that by-pass the stenotic lessions [3] . The growth of these small arteries-called arteriogenesis is triggered by the shear stress due to arterial occlusion [4] . So far, to assess collateral circulation, several high-cost, invasive diagnostic methods have been proposed, but their use at the primary care level is still limited. Therefore, there are several studies searching for a reliable, non-invasive method to assess the presence of collateral microcirculation [5, 6, 7, 8] . In this field, the non-invasive vascular reactivity test, called postocclusive reactive hyperaemia (PORH) gained attention. This procedure is based on the ability of the endothelium to release vasodilator agents like nitric oxide (NO) as a response to proximal arterial occlusion [9] . After occlusion, when the peripheral perfusion (PP) is restored, flow is increasing because of the reduced vascular resistance. An inexpensive method, the photoplethysmography (PPG) has been proposed to determine theese blood volume changes [10] . This optical technique allows detecting blood volume changes during a cardiac cycle, which is recorded by a sensor consisting of a light source and a photo detector, and is represented as perfusion units in mV [7] .
According to the International guidelines on management of patients with PAD, administration of a prostaglandin E1 (PGE1) for 7 to 28 days, facilitate ulcer healing in patients with critical limb ischemia (CLI) [11] . Therefore the aim of the study was to assess endothelial function in patients with PAD using PPG, and to evaluate whether post-occlusive reactive hyperaemia combined with alprostadil-challenge test is a suitable method to identify patients who are candidates for conservative therapy.
Methods
A number of 98 subjects were included in our study: 49 subjects (39 male, 10 female) diagnosed with lower extremity artery disease stage II-III Fontaine, and a healthy control group of 49 subjects (24 male, 25 female); the control group was devided in 2 subgroups of young and elderly individuals. In the PAD group the mean age was 68.45±5.86 years. In the young control group, the mean age was 25.1±3.8 years while in the elderly group 71.0±0.16 years. All of them gave written informed consent and the study was approved by the Ethics Committee of the County Clinical Hospital, Tîrgu Mureș, Romania. Inclusion criteria were: diagnosis of PAD -according to the current guidelines of the European Society of Cardiology (ESC): ABI<0.9, multiple arterial stenotic lesions or total iliofemoral or femoral-popliteal arterial occlusions confirmed on duplex ultrasound. Patients with connective tissue diseases, lymphoedema, and venous thrombosis were excluded from the study. Intermittent claudication was evaluated according to the Edinburgh Claudication Questionnaire [12] . Ankle-brachial index and PORH test were performed at the inclusion. Smoking and caffeine cessation was required for at least two hours before testing. Patients were placed in supine position for at least ten minutes prior to measurements. During examination, room temperature was maintained at 23-24°C. Ankle-brachial index was determined with a 5-10 MHz handheld Doppler device (BiDop ES-100V3 Hadeco®). The PPG measurements were performed with Bidop ES-100V3® hand-held Doppler and transmitted to the Smart-V-Link® software. The sensor was fixed with an adhesive pad on the plantar surface of the affected leg's hallux. A pneumatic cuff was placed proximal to the pad. After baseline peripheral perfusion (PP b ) recording, blood flow was interrupted for a period of three minutes by inflation of the cuff with 20 mmHg above systolic pressure. After cuff deflation at maximum speed, post-occlusive flow was measured for further 4 minutes (1 measurement /minute). Post-occlusive reactive hyperaemia was denoted as the maximum value of the four measurements performed at one minute intervals (PORH b ). After obtaining the PORH b value, intravenous alprostadil (10μg/kg/min) was administrated for 30 minutes. Peripheral perfusion and post-occlusive reactive hyperemia were again determined after alprostadil challenge test (PPc, PORHc). Patients with a lack of increase of peripheral perfusion by at least 50% after administration of alprostadil, were categorized as non-responders (NR) and were referred for surgical revascularization. In the control groups, only baseline measurements were performed (ABI, PP b , PORH b ), alprostadil challenge test was not performed.
Patients' characteristics were collected as raw data. Numerical data were represented as mean±SD. Means were compared using t-test for continuous variables. Correlations were studied using Pearson's correlation test for data presenting Gaussian distribution. Statistical analysis was performed with Graph Pad Instat program. Statistical significance was set at p≤0.05 with confidence interval of 95%.
Results
Among responders ABI was 0.4±0.2, and in non-responders 0.30±0.22. In young controls, ABI was 1.27 ±0.5, and in elderly controls 0.99±0.16.
In responders, the peripheral perfusion increased by 1.58 mV/V (from 0,69 mv/V to 2,27 mV/V) after occlusion ( Figure 1 ) and after vasodilator challenge, peripheral perfusion increased by 3.68 mV/V (from 0,84 mV/V to 4,52 mV/V) (Figure 2 ). In responders, we found no correlation between the ABI and PORH after alprostadil challenge, p=0.83 (Figure 3) .
In the non-responders group, PPb versus PORHb was: 0.6±0.85 mV/V versus 0.67±0.78 (p=0.09) and after alprostadil challenge PPc versus PORHc was: 0,68±1.18 mV/V versus 0.74±1.13 mV/V (p=0.08) (Figure 4 ).
In the young controls group, PPb versus PORHb was 3.7±2.25 mV/V versus 5.3±2.8 mV/V (p<0.0001), while in older controls 2.4±1.7 mV/V versus 3.8±1.5 mV/V, p<0.0001.
Discussion
In our study we evaluated endothelial function as a vasodilator response to arterial occlusion with the non-invasive finger PPG in patients with lower extremity artery disease and critical ankle-brachial index. We found that in patients with PAD, despite the low ABI, post-occlusive peripheral perfusion increased significantly and this vasodilator effect was more pronounced after alprostadil challenge. In the young control group, as well as in elderly patients without PAD, despite the preserved values of ABI, we also observed an increase in peripheral perfusion after arterial occlusion. In our experience, these findings could be explained by the fact that in PAD patients the increase in peripheral perfusion after alprostadil could reflect the endothelial function of the collateral circulation that by-pass the stenosis. In patients with critical ABI, proximal arterial obstruction and the increased shear stress that occurs, trigger a series of Fig. 2 . Difference in peripheral perfusion and PORH after alprostadil challenge test in responders Fig. 1 . Paired t-test for evaluating difference in baseline peripheral perfusion and after reactive hyperaemia in responders inflammatory reaction that results in homing of stem cells and inflammatory cells to the "injured" tissue and the native collaterals are increasing in diameter, ensuring blood supply to the distal zones [13] . This could be the substrate for the observations that this group of patients did not develop gangrene. In our experience in non-responders with critical ABI (<0.5) and the lack of increase in PORH by at least 50% after alprostadil challenge, reflects altered endothelial function of the main arterial branch and maybe the absence of collateral vessels. Thus, for limb salvage this population should benefit of invasive high-cost investigations and surgical revascularisation. The assessment of endothelial function involves expensive equipment with a great financial burden on the healthcare system and unavailable for the primary care system. Therefore, in patients with PAD, in order to triage patients for conservative or revascularization therapy, low-cost, operator-independent screening techniques are required. Post-occlusive reactive hyperaemia assessed by finger PPG showed significant increase in peripheral perfusion due to nitric oxide release after occlusion, which could be due to the presence of collateral microcirculation that by-pass stenotic areas. This effect was potentiated after alprostadil challenge. We found no correlation between ABI and post-occlusive reactive hyperaemia, because while ankle-brachial index is a screening method to identify large vessel disease, the assessment of post-occlusive reactive hyperemia reflects the function of the endothelium and maybe the presence of small collateral circulation. Our experience is that in PAD patients with an increase in PORH after alprostadil challenge, the way towards limb salvage consists in lifestyle modification, smoking cessation, exercise therapy, as well as pharmacotherapy including cilostazol, pentoxifyllin, antiplatelet agents, lipid-lowering agents as well as parenteral administration of PGE1 for 7 to 28 days [14] .
Finger PPG is a low-cost, operator-independent optical technique that enables us to detect blood volume changes in response to post-occlusive hyperemia. Although it seems to be a promising method that helps physicians in therapeutic decision making at the primary care level, there is no consensus available for this technique regarding occlusion time as well as a normal range for PORH.
Conclusions
The fact that in PAD patients with low ankle-brachial index, associated with stenotic lessions, as well as in the healthy control group, PORH increased significantly, allows us to conclude that the post-occlusive reactive hyperemia test reflects the endothelial function. In our opinon, an increase in PORH after alprostadil challenge in PAD patients despite a low ABI could reflect the endothelial function of the collateral vessels, while in healthy subjects the increase in PORH could reflect the endothelial function of the main arterial branch. Although, in PAD patients a comprehensive investigation has to be done, for a screening method at the primary care level, PORH test combined with alprostadil challenge test, could offer an inexpensive screening method in order to help physicians in therapeutic decision making. In our experience, in patients with lower extremity artery disease, and an increase of PORH after vasodilator challenge by at least 50%, conservative therapy with alprostadil, cilostazol, lipid-lowering agents, antiplatelet agents as well as lifestyle modification are able to delay surgical revascularisation. The long-term follow-up of these patients is of major importance, and if conservative therapy fails, surgical approach should be performed. 
